drugset / Trial / NCT02071459

Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA

NCT02071459

Phase 2/3 Completed 107 enrolled University Hospital, Toulouse
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Evaluate the effects of L-Threo DOPS on orthostatic hypotension symptoms and other non-motor symptoms in patients with Multiple System Atrophy (MSA) after 12 weeks following randomization to continued therapy with droxidopa or placebo.

Timeline

Start
2014-01-21
Primary completion
2019-10-28
Completion
2019-10-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Droxidopa Small molecule Oral